The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Transaction #28293 · Form 4 · 0001193125-26-410719

Larimar Therapeutics, Inc. · Stock award · Common Stock

Larimar Therapeutics, Inc. · Transacted September 29, 2026 · Filed October 1, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Larimar Therapeutics, Inc. records a stock award involving Common Stock on September 29, 2026. The reported quantity was 50,000. The filing date is October 1, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001374690
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
50,000
Reported price
0
Reference value
0
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
50,000
Ownership description
Not reported
SEC acceptance time
Oct 1, 2026, 4:27 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

LRMR · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2
The option vests 25% on September 29, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.